TARS vs AAPL: Which Stock is Better?
Side-by-side comparison of Tarsus Pharmaceuticals Inc and Apple Inc in 2026
TARS
Tarsus Pharmaceuticals Inc
$67.72
AAPL
Apple Inc
$269.02
Key Metrics Comparison
| Metric | TARS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $3.06B | N/A | TARS |
| P/E Ratio | N/A | 33.68 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | 1.3% | 0.2% | TARS |
| Gross Margin | 79.0% | 47.3% | TARS |
Analyze TARS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TARS or AAPL a better investment?
Comparing TARS and AAPL: Tarsus Pharmaceuticals Inc has a market cap of $3.06B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TARS and AAPL?
TARS (Tarsus Pharmaceuticals Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TARS or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TARS or AAPL?
TARS has higher revenue growth at 1.3% vs 0.2% for AAPL.
Which company is more profitable: TARS or AAPL?
Tarsus Pharmaceuticals Inc (TARS) has higher gross margins at 79.0% compared to 47.3% for AAPL.
Which is the larger company: TARS or AAPL?
Tarsus Pharmaceuticals Inc (TARS) is larger with a market cap of $3.06B compared to N/A for AAPL.
Should I buy TARS or AAPL in 2026?
Both TARS and AAPL have investment merit. TARS trades at $67.72 while AAPL trades at $269.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TARS and AAPL stock?
Key differences: Market Cap ($3.06B vs N/A), P/E Ratio (N/A vs 33.7x), Revenue Growth (1.3% vs 0.2%), Gross Margin (79.0% vs 47.3%).